CM 215 Pill - yellow capsule/oblong, 18mm
Generic Name: canagliflozin/metformin
Pill with imprint CM 215 is Yellow, Capsule/Oblong and has been identified as Invokamet 150 mg / 500 mg. It is supplied by Janssen Pharmaceuticals, Inc.
Invokamet is used in the treatment of Diabetes, Type 2; Cardiovascular Risk Reduction and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Invokamet 150 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CM 215
Invokamet
- Generic Name
- canagliflozin/metformin
- Imprint
- CM 215
- Strength
- 150 mg / 500 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0542
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
water,
polyethylene glycol 3350,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
ferric oxide red
Note: Inactive ingredients may vary.
More about Invokamet (canagliflozin / metformin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
